about
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle ...
Read More
67.56
-1.22
(-1.77%)
1.6M
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Cytokinetics Inc is on 23 Sep 2026 for the purpose of Bernstein 3rd Annual Healthcare Forum
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cytokinetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..